Focused on Women’s Health, CureMetrix AI-based cmAngio™ was highlighted in the July 2021 edition of DOTmed HealthCareBusiness News. cmAngio “represents the potential to screen 40 million women a year for heart disease in the U.S. alone,” with AI that maximizes the mammogram for both breast cancer and heart disease detection.
Navid Alipour, Chief Executive Officer
Recent Posts
Breast Cancer Screening Gets Personal | DOTmed
Topics: News, AI, mammogram, cmTriage, cmAssist, AI Mammogram, CHD, heart disease, cmangio
CureMetrix Joins AuntMinnie and AuntMinnieEurope in Delivering Virtual Conference
The AuntMinnie.com 2020 Virtual Conference takes place April 30 and May 1. The online experience will feature keynote presentations, webinars, interactive trade show booths, and live Q&A sessions focused on top industry subjects.
Topics: AuntMinnie